AB Science S.A. (AB)
Euronext
Closed
Oct 9, 2026
Day's Range
0.516052 wk Range
0.5010Overview - AB - AB Science S.A.
Key Statistics
Valuation
Enterprise Value
46.93M
P/E (Trailing)
‪-17.46‬
P/E (Forward)
‪-3.74‬
PEG Ratio
‪-3.74‬
Price / Sales (TTM)
‪43.08‬
EV / EBITDA
‪62.99‬
Profitability
Profit Margin
‪-132.62%‬
Operating Margin
‪510.92%‬
Return on Assets
‪1.67%‬
Return on Equity
‪9.05%‬
Ownership
Shares Outstanding
66.36M
Float
18.11M
Held by Insiders
‪47.70%‬
Held by Institutions
‪0.0030%‬
Price stats
Beta
‪1.22‬
50-Day Avg
‪0.6907‬
200-Day Avg
‪0.9950‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - AB - AB Science S.A.
Peers - AB - AB Science S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on Euronext.
- ABEuronextAB Science S.A.66.02MMarket Cap-81.29%52-week change-22.80P/E (Trailing)‪-132.62%‬Profit Margin
- IPNEuronextIpsen S.A.11.82BMarket Cap+20.86%52-week change23.19P/E (Trailing)‪11.94%‬Profit Margin
- FAGREuronextFagron NV1.59BMarket Cap+9.79%52-week change17.52P/E (Trailing)‪8.91%‬Profit Margin
- BOIEuronextBoiron SA340.30MMarket Cap-45.41%52-week change12.98P/E (Trailing)‪5.28%‬Profit Margin
- BONEuronextBonduelle SCA234.61MMarket Cap-14.42%52-week change10.97P/E (Trailing)‪2.27%‬Profit Margin
- EAPIEuronextEuroapi S.A.S.U.71.45MMarket Cap-302.14%52-week change8.84P/E (Trailing)‪-40.80%‬Profit Margin
- PIGEuronextHaulotte Group SA64.76MMarket Cap+6.36%52-week change4.58P/E (Trailing)‪-5.54%‬Profit Margin
Profile Summary - AB - AB Science S.A.
About
AB Science S.A. is a clinical-stage pharmaceutical company headquartered in Paris, France, founded in 2001. It specializes in the research, design, development, and marketing of innovative drugs targeting diseases with high unmet medical needs, particularly in oncology, inflammatory diseases, and neurological…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
